Nivolumab For Relapsed Or Residual Haematological Malignancies After Allogeneic Haematopoietic Stem Cell Transplantation (Nivallo)

Eric Wong, Emily Dawson,Joanne Davis,Rachel Koldej,Mandy Ludford-Menting, Matthew Lansdown, Heather Lambie,Jeffrey Szer,Andrew P. Grigg,David Ritchie

BLOOD（2018）

引用 11|浏览19

暂无评分

摘要

Aim: To evaluate the safety and efficacy of nivolumab for the treatment of relapsed or residual haematological malignancies after allogeneic stem cell transplantation (alloSCT).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要